A settlement has been reached in a whistleblower class action lawsuit brought against Johnson & Johnson who is accused of misbranding its drug Natrecor, used to treat heart failure.
Johnson & Johnson has agreed to pay the government a criminal fine of $85 million.
Filed in July 2011, the complaint alleges Johnson & Johnson was misbranding the medicine because its labeling lacked adequate directions for use.